Recent Quotes (30 days)

You have no recent quotes
chg | %

Neovasc Inc  

(Public, CVE:NVC)   Watch this stock  
Find more results for neovasc
- Close
CVE data delayed by 15 mins - Disclaimer
Currency in
Range     -
52 week 2.17 - 7.85
Open     -
Vol / Avg. 0.00/49,835.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -0.11
Shares 53.71M
Beta     -
Inst. own     -
Nov 13, 2014
Q3 2014 Neovasc Inc Earnings Release
Nov 12, 2014
Neovasc Inc at Credit Suisse Healthcare Conference

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -107.48% -57.46%
Operating margin -108.28% -60.51%
EBITD margin - -58.20%
Return on average assets -63.58% -83.12%
Return on average equity -68.94% -103.29%
CDP Score - -


13700 Mayfield Pl Suite 2135
+1-604-2704344 (Phone)
+1-604-2704384 (Fax)

Website links


Neovasc Inc. (Neovasc) is a specialty medical device company that develops, manufactures and markets products for the cardiovascular marketplace. Its products include the Neovasc Reducer for the treatment of refractory angina, the Tiara technology in development for the transcatheter treatment of mitral valve disease and a line of advanced biological tissue products that are used as key components in a variety of third-party medical products, such as vascular surgical patches and transcatheter heart valves. Neovasc manufactures the PeriPatch line of advanced biological tissue products that are manufactured from pericardium, which is the protective sac that surrounds the heart of an animal. The product line includes the PeriPatch Sheet, and PeriPatch EQ Sheet, which are rectangular patches made from bovine (cow) or equine (horse) tissue, applied as internal bandages to repair weak or damaged organs or vessels.

Officers and directors

Paul L. Geyer Chairman of the Board
Age: 46
Alexei J. Marko Chief Executive Officer, Director
Age: 43
Christopher Clark Chief Financial Officer, Corporate Secretary
Brian McPherson Chief Operating Officer
Randy Lane Vice President - Research & Development
Jane H. Hsiao Ph.D. Independent Director
Age: 67
Douglas G. Janzen Independent Director
Age: 41
William O'Neill Independent Director
Age: 61
Steven D. Rubin Esq. Independent Director
Age: 54